[HTML][HTML] Perspective: repurposed drugs for COVID-19
K Na-Bangchang, S Porasuphatana… - Archives of Medical …, 2022 - ncbi.nlm.nih.gov
Methods Research articles and guidelines related to therapy of COVID-19 were searched
from the PubMed database. Results Only remdesivir and tocilizumab are medicines that …
from the PubMed database. Results Only remdesivir and tocilizumab are medicines that …
Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19
Abstract Purpose Coronavirus disease 2019 (COVID-19) has affected millions of people
worldwide and caused mortality. Many factors have been reported to affect the prognosis of …
worldwide and caused mortality. Many factors have been reported to affect the prognosis of …
[PDF][PDF] Фавипиравир как средство терапии COVID-19
КВ Балакин, РВ Стороженко… - Научный бюллетень …, 2023 - chemrar.ru
Фавипиравир, разработанный японскими исследователями в качестве средства
терапии гриппа и других РНК-вирусных инфекций, в 2020-2022 годах стал массово …
терапии гриппа и других РНК-вирусных инфекций, в 2020-2022 годах стал массово …
Evaluation of the use of Favipiravir on the Hematology value of COVID-19 patients at Anna Bekasi Hospital in 2021
F Setiadi, W Widyastuti - PHARMACY: Jurnal Farmasi …, 2023 - jurnalnasional.ump.ac.id
The COVID-19 pandemic caused by the SARS-CoV-2 virus occurred in Indonesia in early
2020. Favipiravir was used as an antiviral for the disease due to an emergency. The results …
2020. Favipiravir was used as an antiviral for the disease due to an emergency. The results …
EVALUASI PENGGUNAAN ANTIVIRUS PADA PASIEN DEWASA COVID-19 DI INSTALASI RAWAT INAP RSUD DR. TJITROWARDOJO KABUPATEN PURWOREJO …
VE Purwantari - 2023 - repository.unimugo.ac.id
Background, COVID-19 is an infectious disease caused by the Severe Acute Respiratory
Syndrome Coronavirus-2 (SARS-CoV-2). Until now, cases of COVID-19 are still increasing …
Syndrome Coronavirus-2 (SARS-CoV-2). Until now, cases of COVID-19 are still increasing …
[HTML][HTML] Comparing the Efficacy of Remdesivir, Favipiravir, and Casirivimab and Imdevimab on Duration of Hospitalization and ICU Stay of Hospitalized COVID-19 …
SK Hegazy, AH Hassan - Life Science Research Communications, 2024 - lifesci.com.sg
Objectives The coronavirus disease of 2019 (COVID-19) disease advances science's ability
to address this catastrophe. Additionally, there have been numerous therapeutic advances …
to address this catastrophe. Additionally, there have been numerous therapeutic advances …